Emerald Mutual Fund Advisers Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.7M Sell
295,317
-45,658
-13% -$1.66M 0.65% 59
2025
Q1
$12.3M Buy
340,975
+16,538
+5% +$599K 0.88% 43
2024
Q4
$13.6M Sell
324,437
-104,865
-24% -$4.41M 0.83% 48
2024
Q3
$23.8M Buy
429,302
+38,778
+10% +$2.15M 1.24% 28
2024
Q2
$16.1M Buy
390,524
+5,184
+1% +$213K 0.84% 48
2024
Q1
$18M Hold
385,340
0.94% 41
2023
Q4
$18.4M Sell
385,340
-1,983
-0.5% -$94.8K 0.98% 39
2023
Q3
$13.8M Sell
387,323
-52,818
-12% -$1.88M 0.83% 51
2023
Q2
$20.3M Buy
440,141
+51,613
+13% +$2.38M 1.1% 32
2023
Q1
$15.6M Buy
388,528
+135,676
+54% +$5.44M 0.92% 42
2022
Q4
$11.7M Buy
252,852
+14,648
+6% +$679K 0.73% 59
2022
Q3
$9.86M Buy
238,204
+71,866
+43% +$2.98M 0.62% 66
2022
Q2
$9.92M Sell
166,338
-15,866
-9% -$947K 0.58% 72
2022
Q1
$13.2M Sell
182,204
-58,565
-24% -$4.25M 0.58% 68
2021
Q4
$20.2M Buy
240,769
+138,892
+136% +$11.7M 0.71% 56
2021
Q3
$9.19M Sell
101,877
-122,205
-55% -$11M 0.32% 97
2021
Q2
$21.4M Sell
224,082
-14,941
-6% -$1.42M 0.7% 57
2021
Q1
$27.2M Buy
239,023
+20,633
+9% +$2.35M 0.9% 34
2020
Q4
$30.2M Buy
+218,390
New +$30.2M 1.05% 27
2017
Q1
Sell
-264,546
Closed -$18.6M 283
2016
Q4
$18.6M Hold
264,546
0.89% 37
2016
Q3
$18.8M Buy
+264,546
New +$18.8M 0.96% 27
2015
Q3
Sell
-52,305
Closed -$5.36M 286
2015
Q2
$5.36M Sell
52,305
-9,020
-15% -$924K 0.41% 91
2015
Q1
$3.65M Sell
61,325
-31,780
-34% -$1.89M 0.3% 101
2014
Q4
$4.09M Buy
93,105
+51,259
+122% +$2.25M 0.35% 91
2014
Q3
$2.37M Buy
41,846
+7,112
+20% +$402K 0.23% 119
2014
Q2
$1.56M Buy
34,734
+12,204
+54% +$548K 0.14% 137
2014
Q1
$1.1M Buy
+22,530
New +$1.1M 0.11% 151